{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:32:20Z","timestamp":1769560340199,"version":"3.49.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T00:00:00Z","timestamp":1767312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"vor","delay-in-days":25,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"ngapore Ministry of Health\u2019s National Medical Research Council","award":["NMRC\/CSA\/021\/2010 and NMRC\/CSA\/0048\/2013"],"award-info":[{"award-number":["NMRC\/CSA\/021\/2010 and NMRC\/CSA\/0048\/2013"]}]},{"name":"Biomedical Research Council of the Agency for Science, Technology and Research","award":["A*STAR"],"award-info":[{"award-number":["A*STAR"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-33831-9","type":"journal-article","created":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T05:07:08Z","timestamp":1767416828000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Subgroup analysis of genotype guided vs traditional warfarin dosing in Asian patients from an open label randomized trial"],"prefix":"10.1038","volume":"16","clinical-trial-number":[{"clinical-trial-number":"nct00700895","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Hon Jen","family":"Wong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yao Neng","family":"Teo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yao Hao","family":"Teo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas L.","family":"Syn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea Li-Ann","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hock-Leun","family":"Teoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raymond C. S.","family":"Seet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soo-Chin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boon-Cher","family":"Goh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2764-2869","authenticated-orcid":false,"given":"Ching-Hui","family":"Sia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,2]]},"reference":[{"key":"33831_CR1","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s12916-018-1093-8","volume":"16","author":"NL Syn","year":"2018","unstructured":"Syn, N. L. et al. Genotype-guided versus traditional clinical dosing of warfarin in patients of Asian ancestry: a randomized controlled trial. BMC Med. 16, 104 (2018).","journal-title":"BMC Med."},{"key":"33831_CR2","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1001\/jama.2016.9356","volume":"316","author":"SD Pokorney","year":"2016","unstructured":"Pokorney, S. D. et al. Stability of International Normalized Ratios in Patients Taking Long-term Warfarin Therapy. JAMA 316, 661\u2013663 (2016).","journal-title":"JAMA"},{"key":"33831_CR3","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.tcm.2014.09.001","volume":"25","author":"JA Johnson","year":"2015","unstructured":"Johnson, J. A. & Cavallari, L. H. Warfarin pharmacogenetics. Trends. Cardiovasc. Med 25, 33\u201341 (2015).","journal-title":"Trends. Cardiovasc. Med"},{"key":"33831_CR4","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1161\/CIRCULATIONAHA.111.070920","volume":"125","author":"JL Anderson","year":"2012","unstructured":"Anderson, J. L. et al. A randomized and clinical effectiveness trial comparing two pharmacogenetic algorithms and standard care for individualizing warfarin dosing (CoumaGen-II). Circulation 125, 1997\u20132005 (2012).","journal-title":"Circulation"},{"key":"33831_CR5","doi-asserted-by":"publisher","first-page":"2294","DOI":"10.1056\/NEJMoa1311386","volume":"369","author":"M Pirmohamed","year":"2013","unstructured":"Pirmohamed, M. et al. A randomized trial of genotype-guided dosing of warfarin. N. Engl. J. Med. 369, 2294\u20132303 (2013).","journal-title":"N. Engl. J. Med."},{"key":"33831_CR6","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1056\/NEJMoa1310669","volume":"369","author":"SE Kimmel","year":"2013","unstructured":"Kimmel, S. E. et al. A Pharmacogenetic versus a Clinical Algorithm for Warfarin Dosing. N. Engl. J. Med. 369, 2283\u20132293 (2013).","journal-title":"N. Engl. J. Med."},{"key":"33831_CR7","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1001\/jama.2017.11469","volume":"318","author":"BF Gage","year":"2017","unstructured":"Gage, B. F. et al. Effect of Genotype-Guided Warfarin Dosing on Clinical Events and Anticoagulation Control Among Patients Undergoing Hip or Knee Arthroplasty: The GIFT Randomized Clinical Trial. JAMA 318, 1115\u20131124 (2017).","journal-title":"JAMA"},{"key":"33831_CR8","doi-asserted-by":"publisher","first-page":"e002602","DOI":"10.1161\/CIRCGEN.119.002602","volume":"13","author":"C Guo","year":"2020","unstructured":"Guo, C. et al. Genotype-Guided Dosing of Warfarin in Chinese Adults: A Multicenter Randomized Clinical Trial. Circ. Genom. Precis Med 13, e002602 (2020).","journal-title":"Circ. Genom. Precis Med"},{"key":"33831_CR9","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1111\/jcpt.13218","volume":"45","author":"Y Zhu","year":"2020","unstructured":"Zhu, Y., Xu, C. & Liu, J. Randomized controlled trial of genotype-guided warfarin anticoagulation in Chinese elderly patients with nonvalvular atrial fibrillation. J. Clin. Pharm. Ther. 45, 1466\u20131473 (2020).","journal-title":"J. Clin. Pharm. Ther."},{"key":"33831_CR10","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1055\/s-0038-1651587","volume":"69","author":"FR Rosendaal","year":"1993","unstructured":"Rosendaal, F. R., Cannegieter, S. C., van der Meer, F. J. & Bri\u00ebt, E. A method to determine the optimal intensity of oral anticoagulant therapy. Thromb. Haemost. 69, 236\u2013239 (1993).","journal-title":"Thromb. Haemost."},{"key":"33831_CR11","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.clpt.2005.11.006","volume":"79","author":"SC Lee","year":"2006","unstructured":"Lee, S. C. et al. Interethnic variability of warfarin maintenance requirement is explained by VKORC1 genotype in an Asian population. Clin. Pharmacol. Ther. 79, 197\u2013205 (2006).","journal-title":"Clin. Pharmacol. Ther."},{"key":"33831_CR12","doi-asserted-by":"publisher","first-page":"e027211","DOI":"10.1161\/JAHA.122.027211","volume":"12","author":"KK Lee","year":"2023","unstructured":"Lee, K. K. et al. Sex Differences in Oral Anticoagulation Therapy in Patients Hospitalized With Atrial Fibrillation: A Nationwide Cohort Study. J. Am. Heart Assoc. 12, e027211 (2023).","journal-title":"J. Am. Heart Assoc."},{"key":"33831_CR13","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1136\/bmj.38698.709572.55","volume":"332","author":"NK Choudhry","year":"2006","unstructured":"Choudhry, N. K. et al. Impact of adverse events on prescribing warfarin in patients with atrial fibrillation: matched pair analysis. BMJ 332, 141\u2013145 (2006).","journal-title":"BMJ"},{"key":"33831_CR14","volume-title":"Review Manager 5 (RevMan 5)","author":"TC Collaboration","year":"2020","unstructured":"Collaboration, T. C. Review Manager 5 (RevMan 5) (The Cochrane Collaboration, 2020)."},{"key":"33831_CR15","doi-asserted-by":"publisher","first-page":"2875","DOI":"10.1016\/j.jacc.2021.04.036","volume":"77","author":"A Lurie","year":"2021","unstructured":"Lurie, A. et al. Prevalence of Left Atrial Thrombus in Anticoagulated Patients With Atrial Fibrillation. J. Am. Coll. Cardiol. 77, 2875\u20132886 (2021).","journal-title":"J. Am. Coll. Cardiol."},{"key":"33831_CR16","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1001\/jama.2021.0716","volume":"325","author":"H Kamran","year":"2021","unstructured":"Kamran, H. et al. Oral Antiplatelet Therapy After Acute Coronary Syndrome: A Review. JAMA 325, 1545\u20131555 (2021).","journal-title":"JAMA"},{"issue":"Suppl 1","key":"33831_CR17","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1111\/j.1538-7836.2007.02499.x","volume":"5","author":"JW Eikelboom","year":"2007","unstructured":"Eikelboom, J. W. & Hirsh, J. Combined antiplatelet and anticoagulant therapy: clinical benefits and risks. J. Thromb. Haemost. 5(Suppl 1), 255\u2013263 (2007).","journal-title":"J. Thromb. Haemost."},{"key":"33831_CR18","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1093\/ptj\/81.9.1502","volume":"81","author":"H van den Berg-Emons","year":"2001","unstructured":"van den Berg-Emons, H., Bussmann, J., Balk, A., Keijzer-Oster, D. & Stam, H. Level of activities associated with mobility during everyday life in patients with chronic congestive heart failure as measured with an \u201cactivity monitor\u201d. Phys. Ther. 81, 1502\u20131511 (2001).","journal-title":"Phys. Ther."},{"key":"33831_CR19","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1111\/j.1741-2358.1999.00069.x","volume":"16","author":"K Walsh","year":"1999","unstructured":"Walsh, K., Roberts, J. & Bennett, G. Mobility in old age. Gerodontology 16, 69\u201374 (1999).","journal-title":"Gerodontology"},{"key":"33831_CR20","doi-asserted-by":"publisher","first-page":"e0285483","DOI":"10.1371\/journal.pone.0285483","volume":"18","author":"L Cadel","year":"2023","unstructured":"Cadel, L. et al. Medication self-management interventions for persons with stroke: A scoping review. PLoS ONE 18, e0285483 (2023).","journal-title":"PLoS ONE"},{"key":"33831_CR21","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1080\/17512433.2023.2187376","volume":"16","author":"C St\u00f6llberger","year":"2023","unstructured":"St\u00f6llberger, C., Schneider, B. & Finsterer, J. Drug-drug interactions with direct oral anticoagulants for the prevention of ischemic stroke and embolism in atrial fibrillation: a narrative review of adverse events. Expert. Rev. Clin. Pharmacol. 16, 313\u2013328 (2023).","journal-title":"Expert. Rev. Clin. Pharmacol."},{"key":"33831_CR22","doi-asserted-by":"publisher","first-page":"780080","DOI":"10.3389\/fneur.2021.780080","volume":"12","author":"V Huppertz","year":"2021","unstructured":"Huppertz, V. et al. Impaired Nutritional Condition After Stroke From the Hyperacute to the Chronic Phase: A Systematic Review and Meta-Analysis. Front. Neurol. 12, 780080 (2021).","journal-title":"Front. Neurol."},{"key":"33831_CR23","doi-asserted-by":"publisher","first-page":"216","DOI":"10.2165\/00003088-197803030-00003","volume":"3","author":"K Krishnaswamy","year":"1978","unstructured":"Krishnaswamy, K. Drug Metabolism and Pharmacokinetics in Malnutrition. Clin. Pharmacokinet. 3, 216\u2013240 (1978).","journal-title":"Clin. Pharmacokinet."},{"key":"33831_CR24","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.neuint.2019.01.025","volume":"127","author":"UV Wesley","year":"2019","unstructured":"Wesley, U. V., Bhute, V. J., Hatcher, J. F., Palecek, S. P. & Dempsey, R. J. Local and systemic metabolic alterations in brain, plasma, and liver of rats in response to aging and ischemic stroke, as detected by nuclear magnetic resonance (NMR) spectroscopy. Neurochem. Int. 127, 113\u2013124 (2019).","journal-title":"Neurochem. Int."},{"key":"33831_CR25","doi-asserted-by":"publisher","first-page":"145","DOI":"10.3390\/metabo14030145","volume":"14","author":"JN Petersson","year":"2024","unstructured":"Petersson, J. N. et al. Unraveling Metabolic Changes following Stroke: Insights from a Urinary Metabolomics Analysis. Metabolites 14, 145 (2024).","journal-title":"Metabolites"},{"key":"33831_CR26","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1161\/CIRCULATIONAHA.121.056355","volume":"145","author":"AP Carnicelli","year":"2022","unstructured":"Carnicelli, A. P. et al. Direct Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation: Patient-Level Network Meta-Analyses of Randomized Clinical Trials With Interaction Testing by Age and Sex. Circulation 145, 242\u2013255 (2022).","journal-title":"Circulation"},{"key":"33831_CR27","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1111\/jcpt.13343","volume":"46","author":"D Wadsworth","year":"2021","unstructured":"Wadsworth, D. et al. A review of indications and comorbidities in which warfarin may be the preferred oral anticoagulant. J. Clin. Pharm. Ther. 46, 560\u2013570 (2021).","journal-title":"J. Clin. Pharm. Ther."},{"key":"33831_CR28","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1038\/tpj.2016.41","volume":"16","author":"TI Verhoef","year":"2016","unstructured":"Verhoef, T. I. et al. Cost-effectiveness of pharmacogenetic-guided dosing of warfarin in the United Kingdom and Sweden. Pharmacogenomics J. 16, 478\u2013484 (2016).","journal-title":"Pharmacogenomics J."},{"key":"33831_CR29","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1161\/CIRCOUTCOMES.108.808592","volume":"2","author":"AR Patrick","year":"2009","unstructured":"Patrick, A. R., Avorn, J. & Choudhry, N. K. Cost-Effectiveness of Genotype-Guided Warfarin Dosing for Patients With Atrial Fibrillation. Circulation Cardiovasc. Qual. Outcomes 2, 429\u2013436 (2009).","journal-title":"Circulation Cardiovasc. Qual. Outcomes"},{"key":"33831_CR30","doi-asserted-by":"publisher","first-page":"498","DOI":"10.3892\/br.2016.599","volume":"4","author":"X Sun","year":"2016","unstructured":"Sun, X., Yu, W. Y., Ma, W. L., Huang, L. H. & Yang, G. P. Impact of the CYP4F2 gene polymorphisms on the warfarin maintenance dose: A systematic review and meta-analysis. Biomed. Rep. 4, 498\u2013506 (2016).","journal-title":"Biomed. Rep."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-33831-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-33831-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-33831-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T10:48:26Z","timestamp":1769510906000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-33831-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,2]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["33831"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-33831-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,2]]},"assertion":[{"value":"12 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The ethics review committee at the Domain Specific Review Board of the National Healthcare Group approved the protocol (PG01\/11\/06). The study was conducted in accordance with Good Clinical Practice guidelines, and patients provided written informed consent prior to enrollment. All serious adverse events were reported to the Domain Specific Review Board and the Medical Clinical Research Committee, Ministry of Health in accordance with published guidelines. The study is registered at ClinicalTrials.gov (Identifier: NCT00700895 [19\/06\/2008]).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Obtained as part of informed consent taking during the original study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"3670"}}